2015-2019 World Orthopedics Market Dynamics and Trends

September 2015 | 325 pages | ID: 254B81E0FEFEN
Venture Planning Group

Abstracts

This report provides a worldwide strategic overview of the orthopedics market, including forecasts for major geographic regions, market segments and product categories. In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globalization, environmental regulations, etc. The analysis of major market segments, including reconstructive devices, fracture fixation products, arthroscopy, soft tissue repair, spinal implants and instrumentation, bone growth stimulators, power instruments, casting materials, operating room ancillary products and others is provided, as well as a review of the major geographic regions, including U.S., Europe, Japan/Pacific and others. The company profiles include:

• Business, new product development and marketing strategies.
• Anticipated acquisitions and joint ventures.
• Major strengths and weaknesses.
• The U.S. and international sales force size.
• Distribution approaches.
• Major promotional tactics.
• Internally developed and acquired technologies.
• Technical expertise in biotechnology, engineering and other pertinent fields.

Contains 325 pages and 3 tables

Contents

I. INTRODUCTION

II. YERSINIA WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio - Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen - Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho - Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Yersinia Tests
France Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Yersinia Test Volume And Diagnostics Sales Forecast by Market Segment
U.K. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment